Danyel Biotech
Omri Cohen is a seasoned finance professional with extensive experience in leadership roles within the finance sector. Currently serving as Chief Financial Officer at Danyel Biotech since March 2023, Omri previously held the position of Chief Finance Controller at One1 from January 2011 to April 2023, where significant achievements included leading over 10 mergers and acquisitions and managing key departments like Accounting and Payroll. Responsibilities encompassed financial reporting in compliance with IFRS and ISA regulations, implementing ISOX, budgeting for multiple business units, and tax planning. Prior experience as Assistant Finance Controller at Deloitte involved leading audit teams for public companies according to IFRS regulations. Omri holds an MBA in Accounting and Finance, as well as a BA in Accounting and Business Management from The College of Management Academic Studies.
This person is not in any teams
This person is not in any offices
Danyel Biotech
Danyel Biotech is a healthcare company, part of the Gamida for Life Group. This group is an interdisciplinary privately-owned group, designed to provide a focused and comprehensive service of supply and support to the Israeli scientific research community specializing in biotechnology and molecular biology, and to offer a point of contact between academic and medical research groups and their colleagues in the industrial sector.